James C. Foster, a Director at Charles River Laboratories International, Inc. (CRL), executed a significant sale of company stock on July 1, 2026. Foster sold 75,000 shares at a price of $225.00 per share, a transaction valued at approximately $16.88 million.
This transaction represents a notable divestment by a key insider. While insider sales can be driven by various personal financial considerations such as portfolio diversification or tax planning, they are often monitored by market participants for potential insights into internal sentiment.
Charles River Laboratories, a contract research organization, provides a range of services for the pharmaceutical, biotechnology, and medical device industries. The company's stock performance is closely watched within the life sciences sector.